From: Factors affecting affect cardiovascular health in Indonesian HIV patients beginning ART
R | Visit | CMV lysate antibody | CMV IE-1 antibody | ||||||
---|---|---|---|---|---|---|---|---|---|
V0 | V3 | V6 | V12 | V0 | V3 | V6 | V12 | ||
Age | 0.28 | 0.23 | 0.25 | 0.27 | 0.10 | 0.11 | 0.15 | 0.14 | |
CD4 T-cells | V0 | 0.18 | −0.17 | −0.23 | −0.19 | −0.19 | − 0.34 | − 0.35 | − 0.40 |
V3 | 0.04 | −0.09 | −0.10 | −0.08 | −0.15 | −0.15 | 0.01 | 0.02 | |
V6 | 0.10 | −0.01 | −0.05 | −0.02 | −0.13 | −0.13 | −0.24 | − 0.26 | |
V12 | 0.09 | −0.07 | −0.05 | 0.01 | −0.10 | −0.13 | −0.04 | −0.10 | |
HIV RNA | V0 | −0.22 | −0.09 | −0.01 | 0.02 | 0.00 | 0.07 | −0.17 | −0.19 |
V3 | −0.16 | 0.05 | 0.05 | 0.03 | −0.11 | 0.02 | −0.17 | −0.17 | |
V6 | −0.15 | 0.03 | 0.01 | 0.02 | −0.15 | −0.07 | −0.14 | −0.13 | |
V12 | −0.16 | −0.05 | −0.07 | −0.20 | −0.04 | −0.19 | − 0.33 | −0.25 | |
Diameter right | V0 | 0.03 | −0.03 | −0.06 | −0.21 | −0.14 | −0.18 | −0.11 | −0.25 |
V3 | 0.11 | 0.11 | −0.10 | −0.27 | −0.28 | −0.27 | − 0.30 | − 0.46 | |
V6 | 0.00 | −0.15 | −0.27 | − 0.32 | −0.09 | −0.12 | −0.13 | −0.16 | |
V12 | 0.02 | −0.18 | − 0.31 | − 0.29 | 0.04 | −0.12 | −0.22 | −0.19 | |
cIMT right | V0 | 0.08 | 0.17 | 0.18 | 0.21 | −0.03 | 0.10 | 0.27 | 0.31 |
V3 | 0.27 | 0.15 | 0.14 | 0.12 | 0.11 | 0.10 | 0.10 | 0.16 | |
V6 | 0.18 | 0.21 | 0.23 | 0.21 | 0.07 | 0.14 | 0.29 | 0.30 | |
V12 | 0.00 | −0.06 | −0.02 | 0.07 | 0.06 | 0.03 | 0.21 | 0.26 | |
Diameter left | V0 | 0.07 | 0.01 | −0.06 | −0.14 | −0.10 | −0.21 | −0.21 | −0.27 |
V3 | −0.08 | 0.01 | −0.01 | −0.08 | −0.10 | −0.14 | 0.01 | −0.06 | |
V6 | −0.03 | −0.16 | −0.24 | −0.17 | 0.02 | 0.02 | −0.12 | −0.01 | |
V12 | 0.08 | −0.07 | −0.06 | −0.06 | 0.05 | 0.03 | −0.05 | −0.10 | |
cIMT left | V0 | −0.12 | 0.02 | 0.16 | 0.10 | −0.11 | 0.01 | 0.23 | 0.16 |
V3 | 0.14 | 0.03 | 0.03 | 0.02 | 0.02 | −0.07 | −0.12 | −0.02 | |
V6 | −0.09 | 0.07 | 0.10 | 0.15 | 0.10 | 0.08 | 0.11 | 0.19 | |
V12 | 0.10 | 0.12 | 0.05 | 0.04 | 0.10 | −0.02 | 0.10 | 0.03 |